JPS5452730A - Diuretics containing prostaglandin f2alphaanalog compound - Google Patents
Diuretics containing prostaglandin f2alphaanalog compoundInfo
- Publication number
- JPS5452730A JPS5452730A JP11665477A JP11665477A JPS5452730A JP S5452730 A JPS5452730 A JP S5452730A JP 11665477 A JP11665477 A JP 11665477A JP 11665477 A JP11665477 A JP 11665477A JP S5452730 A JPS5452730 A JP S5452730A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- diuretics
- prostaglandin
- tetranor
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002934 diuretic Substances 0.000 title abstract 3
- 229940030606 diuretics Drugs 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 150000003180 prostaglandins Chemical class 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010018092 Generalised oedema Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000024783 anasarca Diseases 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000004702 methyl esters Chemical class 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 229910001414 potassium ion Inorganic materials 0.000 abstract 1
- -1 prostaglandin F2 analog compound Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11665477A JPS5452730A (en) | 1977-09-30 | 1977-09-30 | Diuretics containing prostaglandin f2alphaanalog compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11665477A JPS5452730A (en) | 1977-09-30 | 1977-09-30 | Diuretics containing prostaglandin f2alphaanalog compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5452730A true JPS5452730A (en) | 1979-04-25 |
JPS629091B2 JPS629091B2 (enrdf_load_stackoverflow) | 1987-02-26 |
Family
ID=14692573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11665477A Granted JPS5452730A (en) | 1977-09-30 | 1977-09-30 | Diuretics containing prostaglandin f2alphaanalog compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5452730A (enrdf_load_stackoverflow) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
-
1977
- 1977-09-30 JP JP11665477A patent/JPS5452730A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
Also Published As
Publication number | Publication date |
---|---|
JPS629091B2 (enrdf_load_stackoverflow) | 1987-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4113778A (en) | 2-Decarboxy-2-hydroxy-methyl-ω-phenoxy-PGE analogs | |
CA2109110A1 (en) | Prostaglandin e1 analogues | |
JPS52143217A (en) | Stable composition containing prostaglandi ne | |
JPS5452730A (en) | Diuretics containing prostaglandin f2alphaanalog compound | |
JPS5419946A (en) | Prostaglandin analog compound and their preparation | |
JPS5236646A (en) | Process for preparation of prostaglandin derivatives and pharmceutical composition containing the compounds as effectual components | |
JPS5430147A (en) | Prostaglandin i, analogues and their preparation | |
JPS5325544A (en) | Prostaglandin-like compounds, their preparation and pharmaceutical compositions containing the same as active ingredients | |
JPS5331649A (en) | Cholesteric compounds | |
JPS5334747A (en) | Prostaglandin-like compounds and their preparation | |
JPS5239658A (en) | Compounds similar to prostaglandin, their preparation, and medicines t herefrom | |
JPS5283435A (en) | Preparation of prostaglandin analogs | |
JPS5297943A (en) | Prostaglandin derivatives | |
JPS5297944A (en) | Prostaglandin derivatives | |
JPS5223048A (en) | Preparation of prostaglandin derivatives | |
JPS5323954A (en) | Cyclopentanone derivatives | |
JPS5227752A (en) | Preparation of novel (16,17-methylene) prostaglandin derivatives | |
JPS5227750A (en) | Prostaglandin analogues,their preparation, and pharmaceutical composit ions containing the same as active ingredient | |
JPS5293749A (en) | Preparation of beta-dihalogenoethenyl-cyclopropane derivatives | |
JPS5291847A (en) | Prostaglandin analogous compounds and their preparation | |
JPS55357A (en) | Preparation of prostaglandin analogue | |
JPS523038A (en) | Prostaglandin analogues, theirpreparation and asactive componens | |
JPS5289654A (en) | Prostaglandin derivatives | |
JPS51125046A (en) | Process for preparing prostaglandin analogues | |
JPS5223047A (en) | Preparation of prostaglandin derivatives |